Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Ted Rogers Centre investigator’s medical implant technology set to go global
Paul Santerre’s latest commercialization success
ECHO program supports efforts to prevent ischemia-reperfusion injury in the heart
A novel peptide may solve this phenomenon
Our 2019 Innovation Fund awards: 3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
Three bold projects target special challenges in HF
World-first technology to clear the heart of dangerous protein deposits
‘Desperate need for therapies for AL amyloid cardiomyopathy’
Confronting one of the world’s greatest health challenges
Collaborative Ted Rogers Centre has taken new aim at heart failure
New tool helps physicians better manage heart failure in the ED
To admit or discharge is of huge consequence
Heart failure care without borders: Medly paves way for new model of care
Medly program paves way for new model of care in HF
A new platform to grow and test heart cells
Radisic lab unveils the Biowire II
Ted Rogers Centre launches four years ago today
Marking the largest gift in Canadian health-care history
Can the design of research space facilitate collaboration?
New questions, new explorations at TBEP and beyond